Research


Here’s one reason why expensive stocks can continue to climb

MIT’s Andrew Lo On Adaptive Markets, Passive Indexing, And Systemic Shocks

It really is different this time for high-flying stock market

“How Much Brain Damage Do I Have?”

A biotech company focused on inherited diseases just raised $135 million from a bunch of Wall Street firms

A dangerous complacency: Why investors should prepare for a bull-market reversal

Anthony Hilton: We Really Need People Who Understand Tech

“Kill All The Quants”?: Models vs. Mania In The Current Financial Crisis

MIT Sloan School of Management launches new Healthcare Finance course; expands existing FinTech Ventures

Wall Street’s Next Frontier Is Hacking Into Emotions of Traders